JP2006525786A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525786A5
JP2006525786A5 JP2004563747A JP2004563747A JP2006525786A5 JP 2006525786 A5 JP2006525786 A5 JP 2006525786A5 JP 2004563747 A JP2004563747 A JP 2004563747A JP 2004563747 A JP2004563747 A JP 2004563747A JP 2006525786 A5 JP2006525786 A5 JP 2006525786A5
Authority
JP
Japan
Prior art keywords
seq
btl
amino acids
protein
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004563747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525786A (ja
JP4671694B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040338 external-priority patent/WO2004058986A2/en
Publication of JP2006525786A publication Critical patent/JP2006525786A/ja
Publication of JP2006525786A5 publication Critical patent/JP2006525786A5/ja
Application granted granted Critical
Publication of JP4671694B2 publication Critical patent/JP4671694B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004563747A 2002-12-23 2003-12-19 Btl−ii核酸、タンパク質および抗体 Expired - Fee Related JP4671694B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43618502P 2002-12-23 2002-12-23
US52529803P 2003-11-26 2003-11-26
PCT/US2003/040338 WO2004058986A2 (en) 2002-12-23 2003-12-19 Btl-ii nucleic acids, proteins, and antibodies

Publications (3)

Publication Number Publication Date
JP2006525786A JP2006525786A (ja) 2006-11-16
JP2006525786A5 true JP2006525786A5 (https=) 2007-01-25
JP4671694B2 JP4671694B2 (ja) 2011-04-20

Family

ID=32685440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563747A Expired - Fee Related JP4671694B2 (ja) 2002-12-23 2003-12-19 Btl−ii核酸、タンパク質および抗体

Country Status (9)

Country Link
US (4) US7244822B2 (https=)
EP (1) EP1585760B1 (https=)
JP (1) JP4671694B2 (https=)
AU (1) AU2003299687B2 (https=)
CA (1) CA2509999A1 (https=)
ES (1) ES2391949T3 (https=)
MX (1) MXPA05006535A (https=)
PL (2) PL400309A1 (https=)
WO (1) WO2004058986A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130101590A1 (en) * 2010-04-09 2013-04-25 Heather A. Arnett Btnl9 proteins, nucleic acids, and antibodies and uses thereof
US20150166630A1 (en) 2012-07-19 2015-06-18 Amgen Inc. Btnl3 proteins, nucleic acids, and antibodies and uses thereof
JP5830048B2 (ja) * 2013-03-15 2015-12-09 信越化学工業株式会社 チタン含有レジスト下層膜形成用組成物及びパターン形成方法
WO2019028336A1 (en) * 2017-08-03 2019-02-07 The Cleveland Clinic Foundation IMPROVED PEPTIDE EXPRESSION AND ANTIBODY DETECTION OF APO-H SPECIFIC SUBJECT
US20210032334A1 (en) * 2018-02-28 2021-02-04 Dana-Farber Cancer Institute, Inc. Methods for treating cancer using combinations of anti-btnl2 and immune checkpoint blockade agents
US20240327489A1 (en) * 2021-07-20 2024-10-03 Regeneron Pharmaceuticals, Inc. Butyrophilin-like 2 agents for treating inflammatory disorders
CN114437234A (zh) * 2021-12-28 2022-05-06 四川省医学科学院·四川省人民医院 Btnl2重组蛋白及其制备方法与在制备用于治疗炎症性肠病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641809B1 (en) * 1990-03-26 2003-11-04 Bristol-Myers Squibb Company Method of regulating cellular processes mediated by B7 and CD28
US6391311B1 (en) 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US20020168638A1 (en) 2000-01-24 2002-11-14 Robert Schlegel Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
DE10032529A1 (de) 2000-06-30 2002-02-07 Epigenomics Ag Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC)
US20020107363A1 (en) * 2000-09-20 2002-08-08 Amgen, Inc. B7-Like molecules and uses thereof
CA2426540A1 (en) 2000-10-20 2002-07-25 Biocardia, Inc. Leukocyte expression profiling
US20040166490A1 (en) 2002-12-17 2004-08-26 Morris David W. Novel therapeutic targets in cancer
CA2476965A1 (en) 2002-02-20 2003-08-28 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method of modulating e-cadherin mediated cell adhesion

Similar Documents

Publication Publication Date Title
JP2006515749A5 (https=)
JP2021524270A5 (https=)
JP2013517783A5 (https=)
JP2021524275A5 (https=)
JP2013541335A5 (https=)
JP6907229B2 (ja) ヒト化抗clever−1抗体およびその使用
JP2009540801A5 (https=)
JP2012012402A5 (https=)
JP7146926B2 (ja) Cd4ヘルパーt細胞エピトープの融合ペプチドおよびそのワクチン
CN102149406A (zh) 用于治疗丙型肝炎的组合物和方法
JP2005523681A5 (https=)
JP2015524413A5 (https=)
JP2008545393A5 (https=)
JP2006525786A5 (https=)
Namkoong et al. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
JP2010517544A5 (https=)
JP2010538619A5 (https=)
JP6213969B2 (ja) 免疫原性ポリペプチド表層発現ビフィズス菌
JP2010535504A5 (https=)
CA3180251A1 (en) Cytokine conjugates
JP2010514698A5 (https=)
CA3192632A1 (en) Herpesvirus polyepitope vaccines
JP7554423B2 (ja) デングウイルスワクチン
CN113166252A (zh) 全人抗gitr抗体及其制备方法
JP5097135B2 (ja) B型肝炎ワクチンの免疫応答を促進するタンパク質およびその遺伝子